Unique ID issued by UMIN | UMIN000034091 |
---|---|
Receipt number | R000038855 |
Scientific Title | The effects of electrical stimulation for lower limbs to maintenance hemodialysis patients with frailty receiving carnitine: A pilot study |
Date of disclosure of the study information | 2018/10/31 |
Last modified on | 2022/03/15 11:10:10 |
The effects of electrical stimulation for lower limbs to maintenance hemodialysis patients with frailty receiving carnitine: A pilot study
The effects of electrical stimulation for hemodialysis patients receiving carnitine
The effects of electrical stimulation for lower limbs to maintenance hemodialysis patients with frailty receiving carnitine: A pilot study
The effects of electrical stimulation for hemodialysis patients receiving carnitine
Japan |
hemodialysis patients
Nephrology | Rehabilitation medicine |
Others
NO
We will investigate carnitine and electrical stimulation therapy of the lower extremities to maintenance dialysis patients and subsequently examine and compare capacity of for physical activity such as muscle strength, circulatory function, anemia, as well as the effectiveness of these treatments in preventing incidents such as fall events.
Safety,Efficacy
Phase II
Physical activity
biochemical effects
Interventional
Parallel
Randomized
Individual
Open -but assessor(s) are blinded
Active
3
Treatment
Medicine | Device,equipment |
We administer to the patients levocarnitine 1000 mg/dose during every dialysis for 3 months and compare with the sedentary group.
We administer to the patients levocarnitine 1000 mg/dose during every dialysis for 3 months and compare with the levocarnitin + electrical stimulation group.
Sedentary group that underwent standard hemodialysis treatment without any specific therapy.
40 | years-old | <= |
90 | years-old | > |
Male and Female
1. Disease stage is Stage 5 CKD.
2. Physical status is long-term care level 3 or higher (even if prior to official receipt of care level certification).
3. Patients who have provided their informed written consent to participation in the study.
1. Patients presenting with unstable angina, acute phase acute coronary syndrome, hemodynamic instability, or resting SpO2 lower than 90.
2. Patients exhibiting a marked decline in cognitive functions, patients wearing pacemaker devices, or pregnant women.
3. Other patients deemed by a physician to be otherwise unsuitable for participation in this study.
45
1st name | Misa |
Middle name | |
Last name | Miura |
Tsukuba University of technology
Faculty of Health Sciences
305-8521
Kasuga 4-12-7, Tsukuba City, Ibaraki
029-858-9552
m.miura@k.tsukuba-tech.ac.jp
1st name | Aki |
Middle name | |
Last name | Hirayama |
Tsukuba University of technology
Faculty of Health Sciences
305-8521
Kasuga 4-12-7, Tsukuba City, Ibaraki 305-8521
029-858-9552
aki-hira@k.tsukuba-tech.ac.jp
Tsukuba University of technology
Tsukuba University of technology
Government offices of other countries
Japan
Hirayama hospital
Tsukuba University of Technology
4-12-7 Kasuga, Tsukuba City, Ibaraki prefecture, Japan
029-858-9552
m.miura@k.tsukuba-tech.ac.jp
NO
平山病院
2018 | Year | 10 | Month | 31 | Day |
Unpublished
Completed
2018 | Year | 11 | Month | 01 | Day |
2018 | Year | 09 | Month | 19 | Day |
2018 | Year | 11 | Month | 05 | Day |
2022 | Year | 01 | Month | 31 | Day |
2022 | Year | 01 | Month | 31 | Day |
2022 | Year | 01 | Month | 31 | Day |
2022 | Year | 03 | Month | 10 | Day |
2018 | Year | 09 | Month | 11 | Day |
2022 | Year | 03 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038855